9 results on '"Johannes CM"'
Search Results
2. Somatic mosaicism reveals clonal distributions of neocortical development
- Author
-
Breuss, Martin W, Yang, Xiaoxu, Schlachetzki, Johannes CM, Antaki, Danny, Lana, Addison J, Xu, Xin, Chung, Changuk, Chai, Guoliang, Stanley, Valentina, Song, Qiong, Newmeyer, Traci F, Nguyen, An, O'Brien, Sydney, Hoeksema, Marten A, Cao, Beibei, Nott, Alexi, McEvoy-Venneri, Jennifer, Pasillas, Martina P, Barton, Scott T, Copeland, Brett R, Nahas, Shareef, Van Der Kraan, Lucitia, Ding, Yan, NIMH Brain Somatic Mosaicism Network, Glass, Christopher K, and Gleeson, Joseph G
- Subjects
Cultured ,Mosaicism ,General Science & Technology ,Cells ,Neurosciences ,Neocortex ,Stem Cell Research ,Clone Cells ,Neurological ,Humans ,Cell Lineage ,Stem Cell Research - Nonembryonic - Non-Human ,Microglia ,NIMH Brain Somatic Mosaicism Network - Abstract
The structure of the human neocortex underlies species-specific traits and reflects intricate developmental programs. Here we sought to reconstruct processes that occur during early development by sampling adult human tissues. We analysed neocortical clones in a post-mortem human brain through a comprehensive assessment of brain somatic mosaicism, acting as neutral lineage recorders1,2. We combined the sampling of 25 distinct anatomic locations with deep whole-genome sequencing in a neurotypical deceased individual and confirmed results with 5 samples collected from each of three additional donors. We identified 259 bona fide mosaic variants from the index case, then deconvolved distinct geographical, cell-type and clade organizations across the brain and other organs. We found that clones derived after the accumulation of 90-200 progenitors in the cerebral cortex tended to respect the midline axis, well before the anterior-posterior or ventral-dorsal axes, representing a secondary hierarchy following the overall patterning of forebrain and hindbrain domains. Clones across neocortically derived cells were consistent with a dual origin from both dorsal and ventral cellular populations, similar to rodents, whereas the microglia lineage appeared distinct from other resident brain cells. Our data provide a comprehensive analysis of brain somatic mosaicism across the neocortex and demonstrate cellular origins and progenitor distribution patterns within the human brain.
- Published
- 2022
3. Gene regulatory networks underlying human microglia maturation
- Author
-
Han, Claudia, Li, Rick, Hansen, Emily, Bennett, Hunter, Poirion, Olivier, Buchanan, Justin, Challacombe, Jean, Fixsen, Bethany, Trescott, Samantha, Schlachetzki, Johannes CM, Preissl, Sebastian, Wang, Allen, O’Connor, Carolyn, Warden, Anna, Shriram, Shreya, Kim, Roy, Nguyen, Celina, Schafer, Danielle, Ramirez, Gabriela, Anavim, Samuel, Johnson, Avalon, Sajti, Eniko, Gupta, Mihir, Levy, Michael, Ben-Haim, Sharona, Gonda, David, Laurent, Louise, Glass, Christopher, and Coufal, Nicole
- Subjects
Pediatric ,Underpinning research ,1.1 Normal biological development and functioning ,Human Genome ,Neurological ,Neurosciences ,Genetics ,2.1 Biological and endogenous factors ,Aetiology ,Biotechnology ,Brain Disorders - Abstract
The fetal period is a critical time for brain development, characterized by neurogenesis, neural migration, and synaptogenesis 1-3 . Microglia, the tissue resident macrophages of the brain, are observed as early as the fourth week of gestation 4 and are thought to engage in a variety of processes essential for brain development and homeostasis 5-11 . Conversely, microglia phenotypes are highly regulated by the brain environment 12-14 . Mechanisms by which human brain development influences the maturation of microglia and microglia potential contribution to neurodevelopmental disorders remain poorly understood. Here, we performed transcriptomic analysis of human fetal and postnatal microglia and corresponding cortical tissue to define age-specific brain environmental factors that may drive microglia phenotypes. Comparative analysis of open chromatin profiles using bulk and single-cell methods in conjunction with a new computational approach that integrates epigenomic and single-cell RNA-seq data allowed decoding of cellular heterogeneity with inference of subtype- and development stage-specific transcriptional regulators. Interrogation of in vivo and in vitro iPSC-derived microglia models provides evidence for roles of putative instructive signals and downstream gene regulatory networks which establish human-specific fetal and postnatal microglia gene expression programs and potentially contribute to neurodevelopmental disorders.
- Published
- 2021
4. Microbiome-microglia connections via the gut-brain axis
- Author
-
Abdel-Haq, Reem, Schlachetzki, Johannes CM, Glass, Christopher K, and Mazmanian, Sarkis K
- Subjects
Intestines ,Neurodevelopmental Disorders ,Immunology ,Brain ,Animals ,Humans ,Neurodegenerative Diseases ,Microglia ,Medical and Health Sciences ,Gastrointestinal Microbiome - Abstract
Microglia, the resident immune cells in the brain, are essential for modulating neurogenesis, influencing synaptic remodeling, and regulating neuroinflammation by surveying the brain microenvironment. Microglial dysfunction has been implicated in the onset and progression of several neurodevelopmental and neurodegenerative diseases; however, the multitude of factors and signals influencing microglial activity have not been fully elucidated. Microglia not only respond to local signals within the brain but also receive input from the periphery, including the gastrointestinal (GI) tract. Recent preclinical findings suggest that the gut microbiome plays a pivotal role in regulating microglial maturation and function, and altered microbial community composition has been reported in neurological disorders with known microglial involvement in humans. Collectively, these findings suggest that bidirectional crosstalk between the gut and the brain may influence disease pathogenesis. Herein, we discuss recent studies showing a role for the gut microbiome in modulating microglial development and function in homeostatic and disease conditions and highlight possible future research to develop novel microbial treatments for disorders of the brain.
- Published
- 2019
5. Distinct effects of chronic dopaminergic stimulation on hippocampal neurogenesis and striatal doublecortin expression in adult mice
- Author
-
Rachele eSalvi, Tobias eSteigleder, Johannes CM eSchlachetzki, Elisabeth eWaldmann, Beate eWinner, Stefan eSchwab, Jürgen eWinkler, and Zacharias eKohl
- Subjects
adult neurogenesis ,nervous system ,Dopamine receptor ,doublecortin ,Dentate Gyrus ,Parkinson Disease ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Striatum ,lcsh:RC321-571 - Abstract
While adult neurogenesis is considered to be restricted to the hippocampal dentate gyrus (DG) and the subventricular zone (SVZ), recent studies in humans and rodents provide evidence for newly generated neurons in regions generally considered as non-neurogenic, e.g. the striatum. Stimulating dopaminergic neurotransmission has the potential to enhance adult neurogenesis in the SVZ and the DG most likely via D2/D3 dopamine (DA) receptors. Here, we investigated the effect of two distinct preferential D2/D3 DA agonists, Pramipexole (PPX) and Ropinirole (ROP), on adult neurogenesis in the hippocampus and striatum of adult naïve mice. To determine newly generated cells in the DG incorporating 5-bromo-2'-deoxyuridine (BrdU) a proliferation paradigm was performed in which two BrdU injections (100 mg/kg) were applied intraperitoneally within 12 hours after a 14-day-DA agonist treatment. Interestingly, PPX, but not ROP significantly enhanced the proliferation in the DG by 42% compared to phosphate buffered saline (PBS)-injected control mice. To analyze the proportion of newly generated cells differentiating into mature neurons, we quantified cells co-expressing BrdU and NeuN 32 days after the last of five BrdU injections (50 mg/kg) applied at the beginning of 14-day DA agonist or PBS administration. Again, PPX only enhanced neurogenesis in the DG significantly compared to ROP- and PBS-injected mice. Moreover, we explored the pro-neurogenic effect of both DA agonists in the striatum by quantifying neuroblasts expressing doublecortin (DCX) in the entire striatum, as well as in the dorsal and ventral sub-regions separately. We observed a significantly higher number of DCX+ neuroblasts in the dorsal compared to the ventral sub-region of the striatum in PPX-injected mice. These results suggest that the stimulation of hippocampal and dorsal striatal neurogenesis may be up-regulated by PPX. The increased generation of neural cells, both in constitutively active and quiescent neurogenic niches, might be related to the proportional higher D3 receptor affinity of PPX, non-dopaminergic effects of PPX, or altered motor behavior.
- Published
- 2016
6. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity
- Author
-
Wei, Xiang, Stefanie, Menges, Johannes Cm, Schlachetzki, Holger, Meixner, Anna-Carin, Hoffmann, Ursula, Schlötzer-Schrehardt, Cord-Michael, Becker, Jürgen, Winkler, and Jochen, Klucken
- Subjects
Neurons ,Cell Death ,4-hydroxy-2-nonenal ,Parkinson Disease ,Histidine 50 ,Protein Aggregates ,Mutation ,H50Q mutation ,alpha-Synuclein ,Parkinson’s disease ,Humans ,Alpha synuclein ,Histidine ,Posttranslational modification ,Protein Processing, Post-Translational ,Cells, Cultured ,Research Article - Abstract
Background Aggregation and aggregation-mediated formation of toxic alpha synuclein (aSyn) species have been linked to the pathogenesis of sporadic and monogenic Parkinson’s disease (PD). A novel H50Q mutation of aSyn, resulting in the substitution of histidine by glutamine, has recently been identified in PD patients. We have previously shown that the lipid peroxidation product 4-hydroxy-2-nonenal (HNE) induces the formation of HNE-aSyn adducts, thereby promoting aSyn oligomerization and increasing its extracellular toxicity to human dopaminergic neurons. Intriguingly, we identified histidine 50 (H50) of aSyn as one of the HNE modification target residues. These converging lines of evidence support the hypothesis that changes in H50 via posttranslational modification (PTM) and mutation trigger the formation of aggregated, toxic aSyn species, which interfere with cellular homeostasis. In the present study, we aim to elucidate 1) the role of H50 in HNE-mediated aSyn aggregation and toxicity, and 2) the impact of H50 mutation on aSyn pathology. Besides the PD-related H50Q, we analyze a PD-unrelated control mutation, in which H50 is replaced by an arginine residue (H50R). Results Analysis of HNE-treated aSyn revealed that H50 is the most susceptible residue of aSyn to HNE modification and is crucial for HNE-mediated aSyn oligomerization. Overexpression of aSyn with substituted H50 in H4 neuroglioma cells reduced HNE-induced cell damage, indicating a pivotal role of H50 in HNE modification-induced aSyn toxicity. Furthermore, we showed in vitro that H50Q/R mutations substantially increase the formation of high density and fibrillar aSyn species, and potentiate the oligomerization propensity of aSyn in the presence of a nitrating agent. Cell-based experiments also revealed that overexpression of H50Q aSyn in H4 cells promotes aSyn oligomerization. Importantly, overexpression of both H50Q/R aSyn mutants in H4 cells significantly increased cell death when compared to wild type aSyn. This increase in cell death was further exacerbated by the application of H2O2. Conclusion A dual approach addressing alterations of H50 showed that either H50 PTM or mutation trigger aSyn aggregation and toxicity, suggesting an important role of aSyn H50 in the pathogenesis of both sporadic and monogenic PD. Electronic supplementary material The online version of this article (doi:10.1186/s13024-015-0004-0) contains supplementary material, which is available to authorized users.
- Published
- 2014
7. Frontotemporal dementia and its subtypes: a genome-wide association study
- Author
-
Ferrari, Raffaele, Hernandez, Dena G, Nalls, Michael A, Rohrer, Jonathan D, Ramasamy, Adaikalavan, Kwok, John BJ, Dobson-Stone, Carol, Brooks, William S, Schofield, Peter R, Halliday, Glenda M, Hodges, John R, Piguet, Olivier, Bartley, Lauren, Thompson, Elizabeth, Haan, Eric, Hernández, Isabel, Ruiz, Agustín, Boada, Mercè, Borroni, Barbara, Padovani, Alessandro, Cruchaga, Carlos, Cairns, Nigel J, Benussi, Luisa, Binetti, Giuliano, Ghidoni, Roberta, Forloni, Gianluigi, Galimberti, Daniela, Fenoglio, Chiara, Serpente, Maria, Scarpini, Elio, Clarimón, Jordi, Lleó, Alberto, Blesa, Rafael, Waldö, Maria Landqvist, Nilsson, Karin, Nilsson, Christer, Mackenzie, Ian RA, Hsiung, Ging-Yuek R, Mann, David MA, Grafman, Jordan, Morris, Christopher M, Attems, Johannes, Griffiths, Timothy D, McKeith, Ian G, Thomas, Alan J, Pietrini, P, Huey, Edward D, Wassermann, Eric M, Baborie, Atik, Jaros, Evelyn, Tierney, Michael C, Pastor, Pau, Razquin, Cristina, Ortega-Cubero, Sara, Alonso, Elena, Perneczky, Robert, Diehl-Schmid, Janine, Alexopoulos, Panagiotis, Kurz, Alexander, Rainero, Innocenzo, Rubino, Elisa, Pinessi, Lorenzo, Rogaeva, Ekaterina, St George-Hyslop, Peter, Rossi, Giacomina, Tagliavini, Fabrizio, Giaccone, Giorgio, Rowe, James B, Schlachetzki, Johannes CM, Uphill, James, Collinge, John, Mead, Simon, Danek, Adrian, Van Deerlin, Vivianna M, Grossman, Murray, Trojanowski, John Q, van der Zee, Julie, Deschamps, William, Van Langenhove, Tim, Cruts, Marc, Van Broeckhoven, Christine, Cappa, Stefano F, Le Ber, Isabelle, Hannequin, Didier, Golfier, Véronique, Vercelletto, Martine, Brice, Alexis, Nacmias, Benedetta, Sorbi, Sandro, Bagnoli, Silvia, Piaceri, Irene, Nielsen, Jørgen E, Hjermind, Lena E, Riemenschneider, Matthias, Mayhaus, Manuel, Ibach, Bernd, Gasparoni, Gilles, Pichler, Sabrina, Gu, Wei, and Rossor, Martin N
- Subjects
Adult ,Male ,Aging ,Genotype ,Clinical Sciences ,Neurodegenerative ,Rare Diseases ,Clinical Research ,80 and over ,Genetics ,Acquired Cognitive Impairment ,Humans ,2.1 Biological and endogenous factors ,Aetiology ,Alzheimer's Disease Related Dementias (ADRD) ,Aged ,Neurology & Neurosurgery ,Human Genome ,Neurosciences ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Middle Aged ,Brain Disorders ,Frontotemporal Dementia (FTD) ,Frontotemporal Dementia ,Neurological ,Female ,Dementia ,Genome-Wide Association Study - Abstract
BackgroundFrontotemporal dementia (FTD) is a complex disorder characterised by a broad range of clinical manifestations, differential pathological signatures, and genetic variability. Mutations in three genes-MAPT, GRN, and C9orf72--have been associated with FTD. We sought to identify novel genetic risk loci associated with the disorder.MethodsWe did a two-stage genome-wide association study on clinical FTD, analysing samples from 3526 patients with FTD and 9402 healthy controls. To reduce genetic heterogeneity, all participants were of European ancestry. In the discovery phase (samples from 2154 patients with FTD and 4308 controls), we did separate association analyses for each FTD subtype (behavioural variant FTD, semantic dementia, progressive non-fluent aphasia, and FTD overlapping with motor neuron disease [FTD-MND]), followed by a meta-analysis of the entire dataset. We carried forward replication of the novel suggestive loci in an independent sample series (samples from 1372 patients and 5094 controls) and then did joint phase and brain expression and methylation quantitative trait loci analyses for the associated (p
- Published
- 2014
8. Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia
- Author
-
de Oliveira, Antonio CP, Candelario-Jalil, Eduardo, Langbein, Julia, Wendeburg, Lena, Bhatia, Harsharan S, Schlachetzki, Johannes CM, Biber, Knut, and Fiebich, Bernd L
- Subjects
phosphatidylinositol 3-kinase ,Medizinische Fakultät -ohne weitere Spezifikation ,Immunology ,Short Report ,microglia ,lcsh:RC346-429 ,prostaglandins ,Cellular and Molecular Neuroscience ,Polysaccharides ,Animals ,ddc:610 ,Enzyme Inhibitors ,Rats, Wistar ,lcsh:Neurology. Diseases of the nervous system ,Cells, Cultured ,Prostaglandin-E Synthases ,mammalian target of rapamycin ,glycogen synthase kinase-3 ,Cerebral Cortex ,TOR Serine-Threonine Kinases ,Akt ,Rats ,Intramolecular Oxidoreductases ,Oncogene Protein v-akt ,Neurology ,Animals, Newborn ,Gene Expression Regulation ,Cyclooxygenase 2 ,lipids (amino acids, peptides, and proteins) ,Signal Transduction - Abstract
Background Microglia are considered a major target for modulating neuroinflammatory and neurodegenerative disease processes. Upon activation, microglia secrete inflammatory mediators that contribute to the resolution or to further enhancement of damage in the central nervous system (CNS). Therefore, it is important to study the intracellular pathways that are involved in the expression of the inflammatory mediators. Particularly, the role of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) and glycogen synthase kinase-3 (GSK-3) pathways in activated microglia is unclear. Thus, in the present study we investigated the role of Akt and its downstream pathways, GSK-3 and mTOR, in lipopolysaccharide (LPS)-activated primary rat microglia by pharmacological inhibition of these pathways in regard to the expression of cyclooxygenase (COX)-2 and microsomal prostaglandin E synthase-1 (mPGES-1) and to the production of prostaglandin (PG) E2 and PGD2. Findings We show that inhibition of Akt by the Akt inhibitor X enhanced the production of PGE2 and PGD2 without affecting the expression of COX-2, mPGES-1, mPGES-2 and cytosolic prostaglandin E synthase (cPGES). Moreover, inhibition of GSK-3 reduced the expression of both COX-2 and mPGES-1. In contrast, the mTOR inhibitor rapamycin enhanced both COX-2 and mPGES-1 immunoreactivity and the release of PGE2 and PGD2. Interestingly, NVP-BEZ235, a dual PI3K/mTOR inhibitor, enhanced COX-2 and reduced mPGES-1 immunoreactivity, albeit PGE2 and PGD2 levels were enhanced in LPS-stimulated microglia. However, this compound also increased PGE2 in non-stimulated microglia. Conclusion Taken together, we demonstrate that blockade of mTOR and/or PI3K/Akt enhances prostanoid production and that PI3K/Akt, GSK-3 and mTOR differently regulate the expression of mPGES-1 and COX-2 in activated primary microglia. Therefore, these pathways are potential targets for the development of novel strategies to modulate neuroinflammation.
- Published
- 2012
9. Complete genome sequence of Syntrophobacter fumaroxidans strain (MPOB(T))
- Author
-
Plugge, Caroline M, Henstra, Anne M, Worm, Petra, Swarts, Daan C, Paulitsch-Fuchs, Astrid H, Scholten, Johannes CM, Lykidis, Athanasios, Lapidus, Alla L, Goltsman, Eugene, Kim, Edwin, McDonald, Erin, Rohlin, Lars, Crable, Bryan R, Gunsalus, Robert P, Stams, Alfons JM, and McInerney, Michael J
- Subjects
Anaerobic ,sulfate reducer ,Human Genome ,propionate conversion ,Syntrophobacteraceae ,Gram-negative ,Methanospirillum hungatei ,Syntrophobacter fumaroxidans ,mesophile ,host-defense systems ,syntrophy ,Genetics ,Biochemistry and Cell Biology ,Biotechnology - Abstract
Syntrophobacter fumaroxidans strain MPOB(T) is the best-studied species of the genus Syntrophobacter. The species is of interest because of its anaerobic syntrophic lifestyle, its involvement in the conversion of propionate to acetate, H2 and CO2 during the overall degradation of organic matter, and its release of products that serve as substrates for other microorganisms. The strain is able to ferment fumarate in pure culture to CO2 and succinate, and is also able to grow as a sulfate reducer with propionate as an electron donor. This is the first complete genome sequence of a member of the genus Syntrophobacter and a member genus in the family Syntrophobacteraceae. Here we describe the features of this organism, together with the complete genome sequence and annotation. The 4,990,251 bp long genome with its 4,098 protein-coding and 81 RNA genes is a part of the Microbial Genome Program (MGP) and the Genomes to Life (GTL) Program project.
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.